TVGN vs UPB

Tevogen Bio Holdings Inc. vs Upstream Bio, Inc. — Valuation Comparison 2026

TVGN

Biotechnology
Tevogen Bio Holdings Inc.
Quality
3.0
out of 10
Value Trap
24
SAFE
Price
$8.04
Last close
Models
7/13
Active
VS

UPB

Biotechnology
Upstream Bio, Inc.
Quality
5.9
out of 10
Value Trap
12
SAFE
Price
$8.32
Last close
Models
9/13
Active

Model-by-Model Comparison

ModelType TVGN Fair ValueTVGN Upside UPB Fair ValueUPB Upside
Bayesian DCF Intrinsic $1.95 -75.7% $3.18 -61.8%
First Chicago Scenario $•••.•• ••.•% $•••.•• ••.•%
ML-RIV Intrinsic $•••.•• ••.•% $•••.•• ••.•%
Dynamic NAV Asset-Based $0.41 -94.9% $5.79 -30.4%
PWERM Option-Based $•••.•• ••.•% $•••.•• ••.•%
Regime Cross-Sectional Relative $•••.•• ••.•% $•••.•• ••.•%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
FTNN Topology Relative $•••.•• ••.•% $•••.•• ••.•%
🔒

Unlock Full 13-Model Comparison

Access all valuation models for TVGN vs UPB — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

TVGN vs UPB — Which Stock Is More Undervalued?

UPB scores higher with a 5.9/10 quality rating vs TVGN's 3.0/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Tevogen Bio Holdings Inc. (TVGN) and Upstream Bio, Inc. (UPB) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

TVGN currently trades at $8.04 with a QOC of 3.0/10, while UPB trades at $8.32 with a QOC of 5.9/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).